Trial Profile
Clinical and Therapeutic Evaluation of Meloxicam in Mexican Patients With Rheumatic Diseases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2014
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary)
- Indications Rheumatic disorders
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 14 Jul 2014 New trial record